作者:Shivaji V. More、Tzu Ting Chang、Yu-Pin Chiao、Shu-Chuan Jao、Chung-Kuang Lu、Wen-Shan Li
DOI:10.1016/j.ejmech.2013.03.044
日期:2013.6
Three, new, fully synthetic glycosylated isomalyngamide A analogs 4-6 were prepared and evaluated for their anti-migratory activities in human breast cancer cells. The results of the study show that two glycosylated derivatives 4 and 5, containing mannose and galactose appendages, suppress metastatic events (e.g., migration, invasion and adhesion) in human breast adenocarcinoma MDA-MB-231 cells at "nontoxic" concentration levels. In contrast, derivative 6 that contains a lactose moiety, displays a less potent activity. The findings show that monosaccharide rather than disaccharide appendages to the isomalyngamide A backbone more greatly influence cell migration and invasive ability. Evidence has been gained for a mechanism for inhibition of metastatic activities in MDA-MB-231 cells by 4 and 5, involving inactivation of the expression of p-FAR and paxillin through the integrin-mediated anti-metastatic pathway. (C) 2013 Elsevier Masson SAS. All rights reserved.